News
BriaCell 2024 AACR Preclinical Poster Confirms Strong Anti-Cancer Activity Of Bria-OTS+ And Bria-PROS+ Clinical Candidates For Breast And Prostate Cancer
10 Apr 24
Biotech, News, General
BriaCell Highlights Data For Antibody-Drug Conjugate Resistant And Central Nervous System Metastatic Breast Cancer At AACR 2024
9 Apr 24
News, FDA
BriaCell Receives And Executes Letter Of Intent To Advance Clinical Development Of Breast And Prostate Cancer Immunotherapies
7 Mar 24
Biotech, News, General
BriaCell Provides Update On Alleged Illegal Trading Of Public Securities
27 Feb 24
Biotech, News, Legal, General
BriaCell Reports Prelim Disease Control Rate Of 61% In Evaluable Phase 2 Advanced Breast Cancer Patients Treated With Briacell's Bria-imt Regimen; Control Rate Of 50% Reported In Evaluable Patients Who Failed Prior ADC Therapy
7 Feb 24
Biotech, News, General
Press releases
BriaCell to Present Clinical Data in Central Nervous System (CNS) Metastasis and Antibody-Drug Conjugate (ADC) Resistant Breast Cancer at the 2024 AACR Conference
6 Mar 24
News, Press Releases
BriaCell Announces Strong Clinical Data in Breast Cancer Patients; Reports Another Notable Responder Case
7 Feb 24
Press Releases
Breaking Ground in Prostate Cancer: BriaCell Announces Lead Prostate Cancer Candidate Bria-Pros+, Initiates GMP Manufacturing
6 Feb 24
Health Care, Press Releases, General
BriaCell Therapeutics Corp. Announces Results of Shareholder Meeting
30 Jan 24
News, Management, Press Releases